Patents by Inventor Shohei Tanaka

Shohei Tanaka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190119883
    Abstract: A floor mat arranged in a working machine includes a floor portion, a wall portion arranged on a circumferential portion of the floor portion, and an opening portion arranged on a part of a connecting portion of the wall portion, the connecting portion connecting to the floor portion. The floor mat includes a mat main body arranged on the floor portion, a covering portion configured to cover the opening portion, and an connecting portion configured to connect the covering portion flexibly to a circumferential portion of the mat main body.
    Type: Application
    Filed: December 21, 2018
    Publication date: April 25, 2019
    Applicant: KUBOTA CORPORATION
    Inventors: Akihiro ICHIHARA, Kenzo KUSAMA, Kasumi INAGAKI, Hironobu KONISHI, Kazuya OI, Tadayoshi UMEMOTO, Shota SAKAMOTO, Shohei TANAKA, Masahiro AIHARA, Yuta YAMADA, Yoshiki TAKIZAWA, Takuya SAKUTA, Kenichi SAIKI, Tokio SAKATA
  • Patent number: 6987100
    Abstract: Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid or its salt.
    Type: Grant
    Filed: September 2, 2003
    Date of Patent: January 17, 2006
    Assignee: Astellas Pharm Inc.
    Inventors: Shohei Tanaka, Utane Matsukawa, Hironobu Asano
  • Patent number: 6727233
    Abstract: Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-bisphosphonic acid or its salt.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: April 27, 2004
    Assignee: Yamanouchi Pharmaceutical Co., Ltd.
    Inventors: Shohei Tanaka, Utane Matsukawa, Hironobu Asano
  • Publication number: 20040043966
    Abstract: Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both of an effect of suppressing bone resorption accompanying multiple myeloma and an effect of inhibiting multiple myeloma, more particularly, 1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-l,l-bisphosphonic acid or its salt.
    Type: Application
    Filed: September 2, 2003
    Publication date: March 4, 2004
    Applicant: YAMANOUCHI PHARMACEUTICAL CO., LTD.
    Inventors: Shohei Tanaka, Utane Matsukawa, Hironobu Sano
  • Patent number: 5389366
    Abstract: A composition for oral administration to cancer patients includes a neocarzinostatin derivative and from 0.1 and 100 ml per mg of the neocarzinostatin derivative of at least one fatty acid glyceride which has from 6 to 20 carbon atoms and which is noniodized. The composition is effective in the treatment of cancer by oral administration, including a solid cancerous tumor.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: February 14, 1995
    Assignees: Yamanouchi Pharmaceutical Co., Ltd., Hiroshi Maeda, Kuraray Co., Ltd., Kayaku Antibiotics Research Co., Ltd.
    Inventors: Hiroshi Maeda, Fujio Suzuki, Kiichiro Oka, Shohei Tanaka